design lab self-driving nissan toyota ford duke stanford e-hmi

Design Lab Collaborates with Amgen to Explore Adoption of Medical Therapies

Design Lab Collaborates with Amgen to Explore Adoption of Medical Therapies

Design Lab Collaborates with Amgen to Explore Adoption of Medical Therapies

The Design Lab has recently embarked on an exciting collaboration with Amgen to explore the mechanisms driving patients to adopt certain medication therapies.  Dr. Eliah Arnoff-Spencer, senior research scientist Colleen Emmenegger, and researcher Lars Mueller of the Design Lab, received a grant to work on a project aimed at understanding the factors that play a role in key medical decisions through applying human-centered design to healthcare.

Through specifically focusing on the elements of automation and trust within different medical capacities, the team seeks to uncover why patients choose to adopt and either continue or subsequently stop certain therapies.   Automated sensors for diabetes and certain medical treatments are among the areas that the team will target within the healthcare space. Emmenegger, the director of the automation program at The Design Lab, noted that trust is a common theme that transcends both the fields of autonomous vehicles and medicine and will serve as a focal point throughout the project.  

The first step in fostering a shared understanding around patient decisions is to delve deeply into the literature surrounding the adoption and continuation of medical therapies.  Following an analysis of the important insights extracted from existing research, the team plans to conduct interviews with a network of stakeholders within the medical space such as physicians, caregivers, supporters and members of product therapy marketing groups.  Developing an understanding of how trust impacts the community and patients will inform the next phases of the project which will consist of observational studies and site visits of patient homes, doctor’s offices and pharmacies. “It’s never just a single person interacting with a single product – multiple people are always involved and there’s a very distributed nature to these interactions,” says Emmenegger. 

The project marks the start of a long-term partnership with Amgen.  Through interacting with individuals who are involved in making key medical decisions and are knowledgeable about the medical therapy adoption life cycle, Emmenegger is looking forward to learning about the impacts of the study within the larger community.  “This project will teach us not only about trust but also about how to humanize healthcare.”

The Design Lab has recently embarked on an exciting collaboration with Amgen to explore the mechanisms driving patients to adopt certain medication therapies.  Dr. Eliah Arnoff-Spencer, senior research scientist Colleen Emmenegger, and researcher Lars Mueller of the Design Lab, received a grant to work on a project aimed at understanding the factors that play a role in key medical decisions through applying human-centered design to healthcare.

Through specifically focusing on the elements of automation and trust within different medical capacities, the team seeks to uncover why patients choose to adopt and either continue or subsequently stop certain therapies.   Automated sensors for diabetes and certain medical treatments are among the areas that the team will target within the healthcare space. Emmenegger, the director of the automation program at The Design Lab, noted that trust is a common theme that transcends both the fields of autonomous vehicles and medicine and will serve as a focal point throughout the project.  

The first step in fostering a shared understanding around patient decisions is to delve deeply into the literature surrounding the adoption and continuation of medical therapies.  Following an analysis of the important insights extracted from existing research, the team plans to conduct interviews with a network of stakeholders within the medical space such as physicians, caregivers, supporters and members of product therapy marketing groups.  Developing an understanding of how trust impacts the community and patients will inform the next phases of the project which will consist of observational studies and site visits of patient homes, doctor’s offices and pharmacies. “It’s never just a single person interacting with a single product – multiple people are always involved and there’s a very distributed nature to these interactions,” says Emmenegger. 

The project marks the start of a long-term partnership with Amgen.  Through interacting with individuals who are involved in making key medical decisions and are knowledgeable about the medical therapy adoption life cycle, Emmenegger is looking forward to learning about the impacts of the study within the larger community.  “This project will teach us not only about trust but also about how to humanize healthcare.”

The Design Lab has recently embarked on an exciting collaboration with Amgen to explore the mechanisms driving patients to adopt certain medication therapies.  Dr. Eliah Arnoff-Spencer, senior research scientist Colleen Emmenegger, and researcher Lars Mueller of the Design Lab, received a grant to work on a project aimed at understanding the factors that play a role in key medical decisions through applying human-centered design to healthcare.

Through specifically focusing on the elements of automation and trust within different medical capacities, the team seeks to uncover why patients choose to adopt and either continue or subsequently stop certain therapies.   Automated sensors for diabetes and certain medical treatments are among the areas that the team will target within the healthcare space. Emmenegger, the director of the automation program at The Design Lab, noted that trust is a common theme that transcends both the fields of autonomous vehicles and medicine and will serve as a focal point throughout the project.  

The first step in fostering a shared understanding around patient decisions is to delve deeply into the literature surrounding the adoption and continuation of medical therapies.  Following an analysis of the important insights extracted from existing research, the team plans to conduct interviews with a network of stakeholders within the medical space such as physicians, caregivers, supporters and members of product therapy marketing groups.  Developing an understanding of how trust impacts the community and patients will inform the next phases of the project which will consist of observational studies and site visits of patient homes, doctor’s offices and pharmacies. “It’s never just a single person interacting with a single product – multiple people are always involved and there’s a very distributed nature to these interactions,” says Emmenegger. 

The project marks the start of a long-term partnership with Amgen.  Through interacting with individuals who are involved in making key medical decisions and are knowledgeable about the medical therapy adoption life cycle, Emmenegger is looking forward to learning about the impacts of the study within the larger community.  “This project will teach us not only about trust but also about how to humanize healthcare.”

Read Next

Design & Innovation Building (DIB) Grand Opening

Design & Innovation Building (DIB) Grand Opening

In commemoration of the Grand Opening of the new Design & Innovation Building, The Design Lab hosted a showcase of projects and activities on Thursday, November 18. UC San Diego faculty, staff, and students were invited to attend, along with special invitees from the San Diego community such as design practitioners, as well as industry and government partners. The Design & Innovation Building will allow The Design Lab to serve an interdisciplinary group of faculty, students, staff, and community partners that are working to solve the most complex societal problems with design.
Design Lab Melanie Mccomsey Geriatric Thornton Hospital

Improving Senior Care Through Geriatric Emergency Department Research

Geriatric emergency departments  (GEDs) are specialized facilities designed to cater to the medical needs of…

Design Lab Steven Dow Scott Klemmer Student Presentation

Information & Interaction Design: Students Present Ideas to Esteemed Panel

One theme of design classes at UCSD is to learn how to interact with the…

Design Lab Connect2health National Cancer Institute

UC San Diego Design Lab Joins FCC, NCI to Champion Critical Role of Broadband in Rural Cancer Care

The Federal Communications Commission’s Connect2Health Task Force (C2HFCC) announced last week that the FCC and the…

Design and Innovation Building Grand Opening: UCSD’s front door to community collaborations

In November of 2021, the UC San Diego Design Lab unveiled their long-awaited new home in the recently constructed Design and Innovation Building, or as it is affectionately referred to, the DIB. The DIB will serve as a hub for academia, industry and community innovators to participate in design events, lectures, and other working partnerships within the design community that aim to create human-centered solutions to the complex problems facing our region and beyond. The grand opening of the DIB showcased the potential for such gatherings, boasting the presence of organizations like the UCSD Design Co., Girls Who Code, and the Institute of Electrical and Electronics Engineers, to name a few. Such groups showcased current and past projects to the students, professors, and industry leaders in attendance. 

The opening of the DIB marks a momentous occasion in the history of the Design Lab, as the building itself, which is a multi-use environment bringing together multiple disciplines under one roof, represents the journey and philosophy at the heart of the Design Lab’s mission–making UC San Diego a world center for design research and education that fosters a new way of thinking, which addresses the core issues with a systems point of view, and emphasizing the role of people in the complex systems of the modern world.
Design Lab’s Edward Wang Wins NIH R21 For Work On Smartphone-based Alzheimer’s Screening

Design Lab’s Edward Wang wins NIH R21 for work on Smartphone-based Alzheimer’s Screening

Design Lab’s Edward Wang, who is a jointly appointed professor in Electrical & Computer Engineering in Jacobs School of Engineering at UC San Diego, wins a National Institutes of Health (NIH) R21 through the National Institute of Aging (NIA) for his work around transforming smartphones into pocket-sized personal health monitors. 

The NIA has selected Design Lab’s Edward Wang, who directs the Digital Health Lab, to receive NIH R21 funding for his work with Co-investigator Eric Granholm, Director of UCSD’s Center for Mental Health Technology (MHTech), to develop a smartphone app that can screen for early signs of cognitive decline indicative of Alzheimer’s Disease (AD). An NIH R21, also known as the Exploratory/Development Grant, provides support in the early and conceptual stages of a project’s development. As part of a national push towards combating the debilitating effects of AD, the National Institute of Aging looked towards funding novel ways to screen for AD through the use of digital technologies. 
Back To Top